Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Sees Significant Increase in Short Interest

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) saw a large growth in short interest in May. As of May 31st, there was short interest totalling 300 shares, a growth of 50.0% from the May 15th total of 200 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 3,600 shares, the days-to-cover ratio is currently 0.1 days.

Pharma-Bio Serv Stock Performance

PBSV stock remained flat at $0.49 on Tuesday. The company has a market cap of $11.24 million, a P/E ratio of -16.33 and a beta of 0.68. The business’s 50 day moving average price is $0.47 and its 200 day moving average price is $0.51. Pharma-Bio Serv has a 52 week low of $0.31 and a 52 week high of $0.67.

Pharma-Bio Serv (OTCMKTS:PBSV) last released its quarterly earnings results on Monday, March 17th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.35. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%. The business had revenue of $2.47 million during the quarter, compared to the consensus estimate of $2.70 million. Research analysts expect that Pharma-Bio Serv will post 0.11 earnings per share for the current year.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.